Novel blood-based biomarkers for optimizing therapeutic strategies in metastatic prostate cancer
The platelet count, C-reactive protein (CRP) concentration, and chromogranin A concentration—a protein found in neuroendocrine cells—are three important, easily obtainable indicators of failure of combined hormonal therapy in prostate cancer.